FILIP1L and ovarian cancer: These morphological changes were reverted by simultaneous knockdown of FILIP1L and SLUG (Figure 6D), supporting the notion that FILIP1L exerts its anti-tumor activity by suppressing SLUG-mediated EMT in ovarian cancer cells.